IN2013CH04706A - - Google Patents
Info
- Publication number
- IN2013CH04706A IN2013CH04706A IN4706CH2013A IN2013CH04706A IN 2013CH04706 A IN2013CH04706 A IN 2013CH04706A IN 4706CH2013 A IN4706CH2013 A IN 4706CH2013A IN 2013CH04706 A IN2013CH04706 A IN 2013CH04706A
- Authority
- IN
- India
- Prior art keywords
- disorders
- azacytidine
- lyophilized composition
- stable lyophilized
- cancer
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a stable lyophilized composition comprising 5-Azacytidine Form I, and process for preparing thereof. The present invention provides a stable lyophilized composition comprising 5-Azacytidine Form I, and the methods of using a stable lyophilized composition comprising Crystalline 5-Azacytidine Form I for parenteral administration, provided herein to treat diseases or disorders including, e.g., cancer, disorders related to abnormal cell proliferation, hematologic disorders, or immune disorders, among others. In certain embodiments, the pharmaceutical compositions of 5-azacytidine which are parenterally administered to subjects in need thereof to treat a cancer or a hematological disorder, such as, for example, Myelodysplastic syndromes (MDS), acute myelogenous leukemia (AML).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN4706CH2013 IN2013CH04706A (en) | 2013-10-18 | 2013-10-18 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN4706CH2013 IN2013CH04706A (en) | 2013-10-18 | 2013-10-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013CH04706A true IN2013CH04706A (en) | 2015-04-24 |
Family
ID=54398391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN4706CH2013 IN2013CH04706A (en) | 2013-10-18 | 2013-10-18 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013CH04706A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022002905A1 (en) * | 2020-07-01 | 2022-01-06 | Sandoz Ag | Parenteral pharmaceutical composition comprising azacitidine in dmso |
-
2013
- 2013-10-18 IN IN4706CH2013 patent/IN2013CH04706A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022002905A1 (en) * | 2020-07-01 | 2022-01-06 | Sandoz Ag | Parenteral pharmaceutical composition comprising azacitidine in dmso |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016500094A1 (en) | Autotaxin inhibitors | |
PH12016500933A1 (en) | Novel combination treatment for acute myeloid leukemia (aml) | |
MX359989B (en) | Antiviral drugs for treatment of arenavirus infection. | |
PH12013502565A1 (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
WO2017059385A8 (en) | 11,13-modified saxitoxins for the treatment of pain | |
MX2015014947A (en) | Substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones. | |
IN2015DN03327A (en) | ||
WO2014190163A3 (en) | Combination therapy for mds | |
PH12014501913A1 (en) | New 5-alkynyl pyridine | |
MD20150035A2 (en) | Bruton's tyrosine kinase inhibitors | |
MX2016007311A (en) | Methods for treating cancers. | |
MX2020010375A (en) | New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds. | |
MD4643B1 (en) | Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same | |
PH12015502747A1 (en) | Novel compounds for the treatment of cancer | |
MX2020012611A (en) | High surface-area lyophilized compositions comprising arsenic for oral administration in patients. | |
AU2018256668A1 (en) | Combination therapy comprising an inhibitor of JAK, CDK and PIM | |
MD4793C1 (en) | New isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
TN2015000267A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
TN2017000256A1 (en) | Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof | |
WO2014067960A3 (en) | Functionalized 9-bromo-camptothecin derivatives | |
IN2013CH04706A (en) | ||
MX2016004094A (en) | Pharmaceutical composition comprising capecitabine and cyclophosphamide. | |
IN2013MU01226A (en) | ||
WO2015195786A3 (en) | Methods for treating cancers using oral formulations of cytidine analogs | |
IN2013CH05858A (en) |